Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Cazzola

Showing results (91-100 of 802) with videos related to

Pageof 81
Sort By:
Chest|May 4, 2012
Lung blood flow must be considered when prescribing a long-acting β2-agonist/inhaled corticosteroid combinationMario Cazzola, Maria Gabriella Matera
Respiratory Medicine|November 26, 2022
Clinically important deterioration: a composite tool for managing patients with COPDMario Cazzola, Maria Gabriella Matera
Chest|January 14, 2004
Long-acting bronchodilators are the first-choice option for the treatment of stable COPDMario Cazzola, Maria Gabriella Matera
Molecular Aspects of Medicine|March 8, 2022
Molecular aspects of asthmaMario Cazzola, Maria Gabriella Matera
Pulmonary Pharmacology & Therapeutics|December 17, 2005
The need for a new fluoroquinoloneMario Cazzola, Claudio Ferdinando Donner
Handbook of Experimental Pharmacology|October 28, 2016
Muscarinic Receptor AntagonistsMaria Gabriella Matera, Mario Cazzola
Blood|November 16, 2018
Introduction to a review series on iron metabolism and its disordersThomas D Coates, Mario Cazzola
Chest|October 7, 2018
POINT: Should LAMA/LABA Combination Therapy Be Used as Initial Maintenance Treatment for COPD? YesMario Cazzola, Maria Gabriella Matera
Pulmonary Pharmacology & Therapeutics|July 10, 2003
Long-acting beta(2) agonists as potential option in the treatment of acute exacerbations of COPDMario Cazzola, Maria Gabriella Matera
Pulmonary Pharmacology & Therapeutics|January 3, 2012
Tremor and β(2)-adrenergic agents: is it a real clinical problem?Mario Cazzola, Maria Gabriella Matera
Pageof 81

Showing results (91-100 of 802) with videos related to

Sort By:
Pageof 81
Chest|May 4, 2012
Lung blood flow must be considered when prescribing a long-acting β2-agonist/inhaled corticosteroid combinationMario Cazzola, Maria Gabriella Matera
Respiratory Medicine|November 26, 2022
Clinically important deterioration: a composite tool for managing patients with COPDMario Cazzola, Maria Gabriella Matera
Chest|January 14, 2004
Long-acting bronchodilators are the first-choice option for the treatment of stable COPDMario Cazzola, Maria Gabriella Matera
Molecular Aspects of Medicine|March 8, 2022
Molecular aspects of asthmaMario Cazzola, Maria Gabriella Matera
Pulmonary Pharmacology & Therapeutics|December 17, 2005
The need for a new fluoroquinoloneMario Cazzola, Claudio Ferdinando Donner
Handbook of Experimental Pharmacology|October 28, 2016
Muscarinic Receptor AntagonistsMaria Gabriella Matera, Mario Cazzola
Blood|November 16, 2018
Introduction to a review series on iron metabolism and its disordersThomas D Coates, Mario Cazzola
Chest|October 7, 2018
POINT: Should LAMA/LABA Combination Therapy Be Used as Initial Maintenance Treatment for COPD? YesMario Cazzola, Maria Gabriella Matera
Pulmonary Pharmacology & Therapeutics|July 10, 2003
Long-acting beta(2) agonists as potential option in the treatment of acute exacerbations of COPDMario Cazzola, Maria Gabriella Matera
Pulmonary Pharmacology & Therapeutics|January 3, 2012
Tremor and β(2)-adrenergic agents: is it a real clinical problem?Mario Cazzola, Maria Gabriella Matera
Pageof 81